Results: 1-25 | 26-50 | 51-75 | 76-96

Table of contents of journal: *Cancer biotherapy & radiopharmaceuticals

Results: 1-25/96

Authors: DENARDO GL ODONNELL RT OLDHAM RK DENARDO SJ
Citation: Gl. Denardo et al., A REVOLUTION IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 213-223

Authors: BERGHELLA AM PELLEGRINI P CONTASTA I DELBEATO T ADORNO D
Citation: Am. Berghella et al., BCL-2 AND DRUGS USED IN THE TREATMENT OF CANCER - NEW STRATEGIES OF BIOTHERAPY WHICH SHOULD NOT BE UNDERESTIMATED, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 225-237

Authors: DENARDO GL DENARDO SJ LAMBORN KR GOLDSTEIN DS LEVY NB LEWIS JP OGRADY LF RAVENTOS A KROGER LA MACEY DJ MCGAHAN JP MILLS SL SHEN S
Citation: Gl. Denardo et al., LOW-DOSE, FRACTIONATED RADIOIMMUNOTHERAPY FOR B-CELL MALIGNANCIES USING I-131 LYM-1 ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 239-254

Authors: HORNICK JL SHARIFI J KHAWLI LA HU PS BIELA BH MIZOKAMI MM YUN A TAYLOR CR EPSTEIN AL
Citation: Jl. Hornick et al., A NEW CHEMICALLY-MODIFIED CHIMERIC TNT-3 MONOCLONAL-ANTIBODY DIRECTEDAGAINST DNA FOR THE RADIOIMMUNOTHERAPY OF SOLID TUMORS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 255-268

Authors: NADKARNI JJ PERAMBAKAM SM RATHORE VB AMIN KM PARIKH PM NARESH KN ADVANI SH
Citation: Jj. Nadkarni et al., EXPRESSION OF ADHESION MOLECULES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - AN ANALYSIS IN LYMPHOID COMPARTMENTS - PERIPHERAL-BLOOD, BONE-MARROW AND LYMPH-NODE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 269-274

Authors: NAKAMURA K MATSUNAGA K
Citation: K. Nakamura et K. Matsunaga, SUSCEPTIBILITY OF NATURAL-KILLER (NK) CELLS TO REACTIVE OXYGEN SPECIES (ROS) AND THEIR RESTORATION BY THE MIMICS OF SUPEROXIDE-DISMUTASE (SOD), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 275-290

Citation: 7TH CONFERENCE ON RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CANCER - OCTOBER 15-17, 1998 - PRINCETON, NEW-JERSEY - ABSTRACTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 299-329

Authors: OLDHAM RK
Citation: Rk. Oldham, UNTITLED, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 141-141

Authors: WALTER MR BORDENS R NAGABHUSHAN TL WILLIAMS BRG HERBERMAN RB DINARELLO CA BORDEN EC TROTTA PP PESTKA S PFEFFER LM
Citation: Mr. Walter et al., REVIEW OF RECENT DEVELOPMENTS IN THE MOLECULAR CHARACTERIZATION OF RECOMBINANT ALPHA-INTERFERONS ON THE 40TH ANNIVERSARY OF THE DISCOVERY OF INTERFERON, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 143-154

Authors: SCHACHTER J RAKOWSKY E SULKES A ADLER A
Citation: J. Schachter et al., A SEQUENTIAL 4-DRUG CHEMOTHERAPY AND BIOTHERAPY WITH INTERFERON-ALPHAAND GM-CSF - AN INNOVATIVE PROTOCOL FOR THE TREATMENT OF METASTATIC MELANOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 155-164

Authors: DILLMAN RO NAYAK SK BARTH NM DELEON C SCHWARTZBERG LS SPITLER LE CHURCH C OCONNOR AA BEUTEL LD
Citation: Ro. Dillman et al., CLINICAL-EXPERIENCE WITH AUTOLOGOUS TUMOR-CELL LINES FOR PATIENT-SPECIFIC VACCINE THERAPY IN METASTATIC MELANOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 165-176

Authors: ILGAN S YANG DJ HIGUCHI T ZARENEYRIZI F KIM EE PODOLOFF DA
Citation: S. Ilgan et al., IMAGING TUMOR FOLATE RECEPTORS USING (IN)-I-111-DTPA-METHOTREXATE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 177-184

Authors: KAMEI H KOIDE T KOJIMA T HASHIMOTO Y HASEGAWA M
Citation: H. Kamei et al., INHIBITION OF CELL-GROWTH IN CULTURE BY QUINONES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 185-188

Authors: KOIDE T KOJIMA T KAMEI H
Citation: T. Koide et al., ANTITUMOR EFFECT OF GOLD AS REVEALED BY GROWTH SUPPRESSION OF CULTURED CANCER-CELLS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 189-192

Authors: WIMER BM
Citation: Bm. Wimer, IMPLICATIONS OF THE ANALOGY BETWEEN RECOMBINANT CYTOKINE TOXICITIES AND MANIFESTATIONS OF HANTAVIRUS INFECTIONS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 193-207

Authors: NIAKAN B
Citation: B. Niakan, A MECHANISM OF THE SPONTANEOUS REMISSION AND REGRESSION OF CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 209-210

Authors: OLDHAM RK
Citation: Rk. Oldham, TREATMENT OF DRUG-RESISTANCE - BIOTHERAPY OR CHEMOTHERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 69-70

Authors: OLDHAM RK REID WK PREISLER HD BARNETT D
Citation: Rk. Oldham et al., A PHASE-I AND PHARMACOKINETIC STUDY OF CBT-1 AS A MULTIDRUG-RESISTANCE MODULATOR IN THE TREATMENT OF PATIENTS WITH ADVANCED CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 71-80

Authors: JUVEKAR AS AMONKAR AJ DCRUZ AK SAIKAIA T PRADHAN S
Citation: As. Juvekar et al., CHEMOSENSITIVITY OF ADVANCED LARYNX-CARCINOMA CELLS IN-VITRO AND SIGNIFICANCE OF MULTIDRUG-RESISTANCE MARKERS IN THESE TUMORS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 81-87

Authors: PELLEGRINI P BERGHELLA AM DELBEATO T MACCARONE D CASCIANI CU ADORNO D
Citation: P. Pellegrini et al., DISEASE STAGE PROGNOSTIC INDEXES IN THE EARLY CLINICAL SCREENING OF COLORECTAL-CANCER PATIENTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 89-98

Authors: WIMER BM
Citation: Bm. Wimer, IMMUNOSUPPRESSIVE APPLICATIONS OF PHA AND OTHER PLANT MITOGENS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 99-107

Authors: WIMER BM
Citation: Bm. Wimer, PHA FOR APLASTIC ANEMIAS - THE ALPHA BUT NOT THE OMEGA OF MITOGEN THERAPIES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 109-120

Authors: ZARKOVIC N KALISNIK T LONCARIC I BOROVIC S MANG S KISSEL D KONITZER M JURIN M GRAINZA S
Citation: N. Zarkovic et al., COMPARISON OF THE EFFECTS OF VISCUM-ALBUM LECTIN ML-1 AND FRESH PLANT-EXTRACT (ISOREL) ON THE CELL-GROWTH IN-VITRO AND TUMORIGENICITY OF MELANOMA B16F10, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 121-131

Authors: STEFFENS MG KRANENBORG MHGC BOERMAN OC ZEGWAARTHAGEMEIER NEM DEBRUYNE FMJ CORSTENS FHM OOSTERWIJK E
Citation: Mg. Steffens et al., TUMOR RETENTION OF RE-186-MAG3, IN-111-DTPA AND I-125 LABELED MONOCLONAL-ANTIBODY G250 IN NUDE-MICE WITH RENAL-CELL CARCINOMA XENOGRAFTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 133-139

Authors: WEINER G
Citation: G. Weiner, BISPECIFIC ANTIBODY THERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 1-1
Risultati: 1-25 | 26-50 | 51-75 | 76-96